📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
62
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
54%
🔄 Reverse Split
70%
• 50-day avg $0.71 below $1 exchange minimum
• Only 6 months cash — financial pressure
📉 Score Deterioration
40%
• Score rose 23 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 6 months remaining
💹 Market Data
Market Cap$12.34M
Shares Outstanding11.88M
Float2.81M
Cash$1.57M
Debt$121.04M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 55.4% shares (2025Q4 vs prior)
9 institutional holders · 140.9K shares
#1
UBS Group AG
42.1K shares
#2
CITADEL ADVISORS LLC
26.3K shares
#3
SCOTIA CAPITAL INC.
18.0K shares
+ 6 more holders Sign up free to view →
📉 Short Interest
Short Interest31.7K
Days to Cover2.6
% of Float1.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 27, 2022
xbrl
XBRL CONVERTIBLE
Mar 29, 2014
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BGI
📊 BGI FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BGI Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.